Connect with us

Health

WHO reveals that Hepatitis may kill more people than malaria, TB, HIV combined

Published

on

423 Views

The World Health Organisation has raised the alarm that viral hepatitis could kill more people than malaria, tuberculosis, and HIV combined by 2040 if the current infection rate continues.

According to WHO, hepatitis causes liver damage and cancer and kills over a million people annually. Of the 5 types of hepatitis infections, hepatitis B and C cause most of the disease and deaths.

WHO made this known in a statement it issued as the global health body joined the rest of the world to celebrate the 2023 World Hepatitis Day, themed, “One life, one liver”.

The health organisation noted that while Hepatitis C could be cured, only 21 per cent of the people living with the infection are diagnosed and only 13 per cent have received curative treatment.

WHO added that only 10 per cent of people living with chronic hepatitis B are diagnosed, and only 2 per cent of those infected are receiving lifesaving medicine.

“Viral hepatitis could kill more people than malaria, tuberculosis, and HIV combined by 2040 if current infection trends continue.

“Hepatitis causes liver damage and cancer and kills over a million people annually. Of the 5 types of hepatitis infections, hepatitis B and C cause most of the disease and deaths. Hepatitis C can be cured; however, only 21% of people living with hepatitis C infection are diagnosed and only 13% have received curative treatment.

“Just 10 per cent of people living with chronic hepatitis B are diagnosed, and only 2per cent of those infected are receiving the lifesaving medicine.”

WHO emphasised the importance of protecting the liver against hepatitis for living a long, healthy life, saying, “Good liver health also benefits other vital organs – including the heart, b, rain, and kidneys – that rely on the liver to function.”

WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, stated that despite available preventive measures and treatment, many people are undiagnosed.

“Millions of people are living with undiagnosed and untreated hepatitis worldwide, even though we have better tools than ever to prevent, diagnose and treat it.

“WHO remains committed to supporting countries to expand the use of those tools, including increasingly cost-effective curative medication, to save lives and end hepatitis,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.

To combat viral hepatitis, WHo called for global communities to ensure access to treatment for all pregnant women and vaccines for babies at birth.

“To reduce new infections and deaths from hepatitis B and C, countries must: ensure access to treatment for all pregnant women living with hepatitis B, provide hepatitis B vaccines for their babies at birth, diagnose 90% of people living with hepatitis B and/or hepatitis C, and provide treatment to 80% of all people diagnosed with hepatitis.

“They must also act to ensure optimal blood transfusion, safe injections, and harm reduction.

“The reduction of hepatitis B infections in children through vaccination is a key intervention to limit viral hepatitis infections overall. The target for hepatitis B incidence is the only Sustainable Development Goal health target that was met in 2020 and is on track for 2030.

“However, many countries in Africa do not have access to the birth dose hepatitis B vaccines. Gavi’s recent restart of its Vaccine Investment Strategy 2018 – which includes the birth dose hepatitis B vaccine – will jumpstart newborn vaccination programs in West and Central Africa, where mother-to-child hepatitis B transmission rates remain very high.

“To help eliminate mother-to-child transmission, WHO recommends that all pregnant women should be tested for hepatitis B during their pregnancy. If positive, they should receive treatment and vaccines should be provided to their newborns. However, a new WHO report shows that of the 64 countries with a policy, only 32 countries reported implementing activities to screen for and manage hepatitis B in antenatal clinics.

“For people who want to maintain liver health, WHO recommends hepatitis testing, treatment if diagnosed, and vaccination against hepatitis B. Reducing alcohol consumption, achieving a healthy weight, and managing diabetes or hypertension also benefit liver health,” WHO stated.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

WHO Names Nigeria’s Professor Martins Emeje Co-Chair of Traditional Medicine Advisory Group

The appointment of Professor Emeje reflects the WHO’s commitment to inclusive, balanced, and scientifically rigorous leadership in advancing traditional, complementary, and integrative medicine worldwide.

Published

on

By

34 Views

As the Director-General of NNMDA, Professor Emeje has played a pivotal role in promoting research, development, regulation, and commercialization of natural medicines in Nigeria.

The World Health Organisation (WHO) has named Professor Martins Emeje, Director-General of the Nigeria Natural Medicine Development Agency (NNMDA, as Co-Chair of its newly established Strategic and Technical Advisory Group on Traditional, Complementary and Integrative Medicine (STAG-TM).

Professor Emeje was appointed alongside Dr Susan Wieland, Director at Cochrane Complementary Medicine, following the formal unveiling of the Strategic and Technical Advisory Group.

The establishment of STAG-TM marks a significant milestone in the implementation of the WHO Traditional Medicine Strategy, aimed at strengthening global health systems through evidence-based traditional and integrative medicine.

The appointment of Professor Emeje reflects the WHO’s commitment to inclusive, balanced, and scientifically rigorous leadership in advancing traditional, complementary, and integrative medicine worldwide.

Both Co-Chairs bring extensive expertise in research, innovation, and policy development, particularly in natural products and evidence-based medicine.

As the Director-General of NNMDA, Professor Emeje has played a pivotal role in promoting research, development, regulation, and commercialization of natural medicines in Nigeria.

His selection highlights Nigeria’s growing contribution to global health governance and innovation in traditional medicine.

The Strategic and Technical Advisory Group on Traditional, Complementary and Integrative Medicine will provide expert guidance to the WHO on policy frameworks, research priorities, and best practices to ensure the safe, effective, and quality integration of traditional medicine into national healthcare systems.

The W.H.O while announcing the creation of the 19 member Group emphasized that the move is part of its global Traditional Medicine Strategy 2025 describing it as a decisive step in applying a scientific response to traditional medicine.

At the inaugural meeting of the Group, held alongside the second W. H.O Global Traditional Medicine Summit held in New Delhi, India, the W.H.O’s Assistant Director General for Health System,Access and Data, Dr Yukiko Nakatani says it is a pivotal moment for Traditional Medicine as it embodies cultural heritage, national health identities and a vital component of policy healthcare strategies.

The situation whereby the rapid growth of traditional medicine has not been matched by strong evidence, standards, regulatory frameworks or sustainable governance, W.H.O’s Chief Scientist , Dr Sylvie Briand emphasized, underscores the urgency of the initiative.

Continue Reading

Health

Music eases surgery and speeds recovery, Indian study finds

To understand why the researchers turned to music, it helps to decode the modern practice of anaesthesia.

Published

on

By

145 Views

• A patient with headphones playing music during surgery in a hospital in Delhi.

Under the harsh lights of an operating theatre in the Indian capital, Delhi, a woman lies motionless as surgeons prepare to remove her gallbladder.

She is under general anaesthesia: unconscious, insensate and rendered completely still by a blend of drugs that induce deep sleep, block memory, blunt pain and temporarily paralyse her muscles.

Yet, amid the hum of monitors and the steady rhythm of the surgical team, a gentle stream of flute music plays through the headphones placed over her ears.

Even as the drugs silence much of her brain, its auditory pathway remains partly active.

When she wakes up, she will regain consciousness more quickly and clearly because she required lower doses of anaesthetic drugs such as propofol and opioid painkillers than patients who heard no music.

That, at least, is what a new peer-reviewed study from Delhi’s Maulana Azad Medical College and Lok Nayak Hospital suggests.

The research, published in the journal Music and Medicine, offers some of the strongest evidence yet that music played during general anaesthesia can modestly but meaningfully reduce drug requirements and improve recovery.

The study focuses on patients undergoing laparoscopic cholecystectomy, the standard keyhole operation to remove the gallbladder.

The procedure is short – usually under an hour – and demands a particularly swift, “clear-headed” recovery.

To understand why the researchers turned to music, it helps to decode the modern practice of anaesthesia.

“Our aim is early discharge after surgery,” says Dr Farah Husain, senior specialist in anaesthesia and certified music therapist for the study.

“Patients need to wake up clear-headed, alert and oriented, and ideally pain-free. With better pain management, the stress response is curtailed.”

Achieving that requires a carefully balanced mix of five or six drugs that together keep the patient asleep, block pain, prevent memory of the surgery and relax the muscles…

(From BBC)

Continue Reading

Health

Doctors’ strike continues as NARD demands fair deal, better pay

Published

on

152 Views

The Nigerian Association of Resident Doctors (NARD) has urged the Federal Government to immediately conclude the long-delayed Collective Bargaining Agreement (CBA) as the union’s indefinite strike entered its 15th day on Saturday.

The doctors are also demanding a review of the Consolidated Medical Salary Structure (CONMESS), which they described as outdated and inadequate in the face of rising living costs.

In a statement posted on X on Saturday, NARD said doctors have waited too long for a fair and clearly defined agreement on their work conditions and remuneration.

“For long we’ve waited for a Collective Bargaining Agreement (CBA), a simple, written promise that ensures fairness, clear work terms, and proper pay. But the government keeps delaying, while doctors face rising costs and crumbling morale,” the union said.
“We demand the immediate conclusion of the CBA and review of the outdated CONMESS salary structure.”

The ongoing industrial action, which began earlier this month, has disrupted services in 91 hospitals across the country, including federal teaching hospitals, specialist centres, and federal medical centres.

NARD reiterated that its 19-point demand list is vital for improving the welfare of doctors and safeguarding the health sector. Among the demands are the payment of arrears under CONMESS, the disbursement of the 2025 Medical Residency Training Fund, prompt payment of specialist allowances, improved recognition of postgraduate qualifications, and better working conditions.

The union said these measures are essential to keep medical professionals in the system and maintain a functional healthcare delivery structure.

President Bola Tinubu had earlier directed the Ministry of Health to ensure immediate resolution of the strike, assuring that the government is working to address the doctors’ concerns.

However, NARD said the continued delay in signing the CBA and reviewing salaries has further dampened morale among resident doctors, many of whom are battling with economic hardship while providing critical healthcare services.

The union maintained that it remains open to dialogue but expects urgent government action to restore normalcy in the nation’s hospitals.

Continue Reading

Trending